Medtronic (MDT) concluded the recent trading session at $84.76, signifying a +0.19% move from its prior day's close.
Many investors are withdrawing their money from the stock market right now, but those focused on the long term know to hold on through market volatility. In fact, it's still a great time to invest in companies that have excellent underlying businesses and attractive long-term prospects.
Medtronic (MDT) reachead $84.30 at the closing of the latest trading day, reflecting a +0.66% change compared to its last close.
The latest trading day saw Medtronic (MDT) settling at $83.75, representing a +0.46% change from its previous close.
In recent months, Medtronic has soundly outperformed the S&P 500 index. The company's recent regulatory approvals should bode well for non-GAAP EPS growth in the coming years. Medtronic's interest coverage and net debt to EBITDA ratios are robust.
Investors increasingly seek stable and resilient investments in today's volatile and economically uncertain market. Consequently, it is crucial to identify companies with strong fundamentals, defensive strategies, and dependable shareholder returns.
Medtronic offers a compelling long-term investment opportunity with solid revenue and earnings growth, driven by innovation in the cardiovascular, neuromodulation, and diabetes care segments. Medtronic's 3.4% dividend yield is well-supported by earnings, and management continues to invest in R&D to drive shareholder returns. With a forward P/E of 15.1 versus a historical norm of 18.2, MDT is attractively valued amidst improving margins and demographic tailwinds from an aging population.
Medtronic (MDT) concluded the recent trading session at $82.60, signifying a -0.12% move from its prior day's close.
Bill George, executive fellow at Harvard Business School and former CEO and chairman of Medtronic, joins Market Domination Overtime to discuss the most recent tariff developments. George emphasizes how President Trump's tariff policies and policy adjustments erode other nations' trust in the United States.
In the latest trading session, Medtronic (MDT) closed at $88.86, marking a +0.42% move from the previous day.
Medtronic (MDT 2.62%) stock was a fairly hot item as the trading week kicked off, with investors pushing the shares up by almost 3% in value. They liked the medical device specialist's latest piece of news about one of its products, and reacted accordingly.
Healthcare can be a complex sector, and it is one that I long ago decided to outsource to the industry professionals who run closed-end fund Blackrock Health Sciences Trust. But I couldn't resist dipping my toe into the sector when I saw the historically high yield on offer from Medtronic (MDT 0.88%), one of the largest and most diversified medical device makers.